A quantita- tive assessment of plasma homocysteine as a risk factor for vascu- lar disease: probable benefits of increasing folic acid intakes. JAMA. 1995;274:1049 1057. 762. Graham IM, Daly LE, Refsum HM, Robinson K, Brattstrom LE, Ueland PM, Palma-Reis RJ, Boers GH, Sheahan RG, Israelsson B, Uiterwaal CS, Meleady R, McMaster D, Verhoef P, Witteman J, Rubba P, Bellet H, Wautrecht JC, de Valk HW, Sales Luis AC, Parrot-Rouland FM, Tan KS, Higgins I, Garcon D, Medrano MJ, Candito M, Evans AE, Andria G. Plasma homocysteine as a risk factor for vascular disease: the European Concerted Action Project. JAMA. 1997;277:1775 1781. 763. Robinson K, Arheart K, Refsum H, Brattstrom L, Boers G, Ueland P, Rubba P, Palma-Reis R, Meleady R, Daly L, Witteman J, Graham I. Low circulating folate and vitamin B6 concentrations: risk factors for stroke, peripheral vascular disease, and coronary artery disease: European COMAC Group. Circulation. 1998;97:437 443. 764. Bostom AG, Rosenberg IH, Silbershatz H, Jacques PF, Selhub J, D Agostino RB, Wilson PW, Wolf PA. Nonfasting plasma total homo- cysteine levels and stroke incidence in elderly persons: the Framingham Study. Ann Intern Med. 1999;131:352 355. 765. Das RR, Seshadri S, Beiser AS, Kelly-Hayes M, Au R, Himali JJ, Kase CS, Benjamin EJ, Polak JF, O Donnell CJ,Yoshita M, D Agostino RB Sr, DeCarli C, Wolf PA. Prevalence and correlates of silent cerebral infarcts in the Framingham Offspring Study. Stroke. 2008;39:2929 2935. 766. Giles WH, Croft JB, Greenlund KJ, Ford ES, Kittner SJ. Total homocyst(e)ine concentration and the likelihood of nonfatal stroke: results from the Third National Health and Nutrition Examination Survey, 1988 1994. Stroke. 1998;29:2473 2477. 767. Tanne D, Haim M, Goldbourt U, Boyko V, Doolman R, AdlerY, Brunner D, Behar S, Sela BA. 